Publication | Closed Access

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyHematologyPathologyClinical EffectIntensive Combination ChemotherapyOncologyCancer Research